Pfiz­er inks deal with start­up Adap­syn to search mi­crobes for nov­el com­pounds

Pfiz­er is re­cruit­ing Cana­di­an up­start Adap­syn Bio­science to dig for nov­el com­pounds by scrap­ing and crunch­ing ge­nom­ic and metabolom­ic da­ta from mi­crobes. The re­search col­lab­o­ra­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER